{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:23:21Z","timestamp":1790231001416,"version":"4.1.0"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.trsl.2020.02.002","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T17:26:36Z","timestamp":1581528396000},"page":"122-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae"],"prefix":"10.1016","volume":"220","author":[{"given":"Daniel H.F.","family":"Rubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.C.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5646-1314","authenticated-orcid":false,"given":"Yonatan H.","family":"Grad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.trsl.2020.02.002_bib0001","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull World Health Organ"},{"issue":"12","key":"10.1016\/j.trsl.2020.02.002_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.trsl.2020.02.002_bib0003","article-title":"Sexually transmitted infections and screening for chlamydia in England, 2018","volume":"19","year":"2019","journal-title":"Health Prot Rep"},{"key":"10.1016\/j.trsl.2020.02.002_bib0004","series-title":"Annual surveillance report on HIV, viral hepatitis and STIs in Australia 2017","year":"2017"},{"key":"10.1016\/j.trsl.2020.02.002_bib0005","series-title":"Sexually transmitted disease surveillance - 2018","year":"2018"},{"key":"10.1016\/j.trsl.2020.02.002_bib0006","series-title":"WHO guidelines for the treatment of Neisseria gonorrhoeae","year":"2016"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0007","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/OLQ.0000000000000740","article-title":"Narrative review: assessment of Neisseria gonorrhoeae infections among men who have sex with men in national and sentinel surveillance systems in the United States","volume":"45","author":"Weston","year":"2018","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.trsl.2020.02.002_bib0008","series-title":"Principles and practice of infectious disease","article-title":"Neisseria gonorrhoeae (Gonorrhea)","author":"Marazzo","year":"2015"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1258\/0956462021924712","article-title":"What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic?","volume":"13","author":"Korenromp","year":"2002","journal-title":"Int J STD AIDS"},{"issue":"21","key":"10.1016\/j.trsl.2020.02.002_bib0010","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.trsl.2020.02.002_bib0011","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1067\/mob.2002.121625","article-title":"Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial","volume":"186","author":"Ness","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0012","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/(SICI)1099-1557(199611)5:6<409::AID-PDS232>3.0.CO;2-E","article-title":"Incidence of pelvic inflammatory disease among women treated for gonorrhea or chlamydia","volume":"5","author":"Rothman","year":"1996","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.trsl.2020.02.002_bib0013","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1473-3099(18)30341-4","article-title":"Testing for gonorrhoea should routinely include the pharynx","volume":"18","author":"Whittles","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.trsl.2020.02.002_bib0014","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/OLQ.0000000000000093","article-title":"Effect of nucleic acid amplification testing on detection of extragenital gonorrhea and chlamydial infections in men who have sex with men sexually transmitted disease clinic patients","volume":"41","author":"Barbee","year":"2014","journal-title":"Sex Transm Dis"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00007435-198404000-00003","article-title":"Incidence of disseminated gonococcal infection correlated with the presence of AHU auxotype of Neisseria gonorrhoeae in a community","volume":"11","author":"Noble","year":"1984","journal-title":"Sex Transm Dis"},{"issue":"7","key":"10.1016\/j.trsl.2020.02.002_bib0016","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/sextrans-2014-051893","article-title":"The epidemiology of gonococcal arthritis in an Indigenous Australian population","volume":"91","author":"Tuttle","year":"2015","journal-title":"Sex Transm Infect"},{"issue":"7","key":"10.1016\/j.trsl.2020.02.002_bib0017","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/sextrans-2018-053896","article-title":"Kissing may be an important and neglected risk factor for oropharyngeal gonorrhoea: a cross-sectional study in men who have sex with men","volume":"95","author":"Chow","year":"2019","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0018","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3201\/eid2206.ET2206","article-title":"Etymologia: Neisseria","volume":"22","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.trsl.2020.02.002_bib0019","series-title":"The hidden affliction: sexually transmitted infections and infertility in history","article-title":"(The wrong kind of) gonorrhea in antiquity","author":"Flemming","year":"2019"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0020","first-page":"1","article-title":"History of venereal diseases from antiquity to the renaissance","volume":"23","author":"Gruber","year":"2015","journal-title":"Acta dermatovenerol Croat."},{"issue":"22","key":"10.1016\/j.trsl.2020.02.002_bib0021","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1001\/jama.1984.03350220062033","article-title":"The original portrayer of smallpox","volume":"252","author":"Behbehani","year":"1984","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.trsl.2020.02.002_bib0022","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41564-019-0501-y","article-title":"The impact of antimicrobials on gonococcal evolution","volume":"4","author":"S\u00e1nchez-Bus\u00f3","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.trsl.2020.02.002_bib0023","series-title":"A complete practical work on the nature and treatment of venereal diseases: and other affections of the genito-urinary organs of the male and female","author":"Bostwick","year":"1848"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0024","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1353\/pbm.2005.0003","article-title":"Gonorrhea and the beginnings of clinical research ethics","volume":"48","author":"Benedek","year":"2005","journal-title":"Perspect Biol Med"},{"issue":"5","key":"10.1016\/j.trsl.2020.02.002_bib0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/jama.1917.04270020042013","article-title":"The treatment of gonorrheal infections: by the intravenous injection of killed gonococci, meningococci and colon bacilli","volume":"LXVIII","author":"Culver","year":"1917","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0026","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jama.1929.02700280015007","article-title":"Action of mercurochrome and tincture of iodine in skin disinfection: a comparative study","volume":"92","author":"Scott","year":"1929","journal-title":"J Am Med Assoc"},{"issue":"20","key":"10.1016\/j.trsl.2020.02.002_bib0027","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/jama.1935.02760200019005","article-title":"Treatment of gonorrhea in the female: by means of systemic and additional pelvic heating","volume":"104","author":"Bierman","year":"1935","journal-title":"J Am Med Assoc"},{"issue":"24","key":"10.1016\/j.trsl.2020.02.002_bib0028","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1001\/jama.1936.02770500008003","article-title":"The value of fever therapy for gonorrhea","volume":"107","author":"Owens","year":"1936","journal-title":"J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0029","first-page":"81","article-title":"Gonorrhoea and the sulphonamides","volume":"25","author":"Dunlop","year":"1949","journal-title":"Br J Vener Dis"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0030","first-page":"33","article-title":"Development of resistance of gonococci to penicillin: an eight-year study","volume":"96","author":"Amies","year":"1967","journal-title":"Can Med Assoc J"},{"issue":"5","key":"10.1016\/j.trsl.2020.02.002_bib0031","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/infdis\/122.5.459","article-title":"Comparative study of gonococcal susceptibility to penicillin in the United States, 1955-1969","volume":"122","author":"Martin","year":"1970","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.trsl.2020.02.002_bib0032","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.trsl.2020.02.002_bib0033","first-page":"217","article-title":"A survey of problems in the antibiotic treatment of gonorrhoea. With special reference to South-East Asia","volume":"46","author":"Willcox","year":"1970","journal-title":"Br J Vener Dis"},{"issue":"7987","key":"10.1016\/j.trsl.2020.02.002_bib0034","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(76)92467-3","article-title":"Penicilunase-producing neisseria gonorrh\u0152\u00c6","volume":"308","author":"Ashford","year":"1976","journal-title":"Lancet North Am Ed"},{"issue":"Rr-03","key":"10.1016\/j.trsl.2020.02.002_bib0035","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0036","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"2012 European guideline on the diagnosis and treatment of gonorrhoea in adults","volume":"24","author":"Bignell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.trsl.2020.02.002_bib0037","series-title":"Australian STI management guidelines for use in primary care","year":"2019"},{"key":"10.1016\/j.trsl.2020.02.002_bib0038","series-title":"British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae (2019)","author":"Fifer","year":"2019"},{"issue":"370","key":"10.1016\/j.trsl.2020.02.002_bib0039","article-title":"Notice to readers: discontinuation of spectinomycin","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.trsl.2020.02.002_bib0040","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/OLQ.0000000000000819","article-title":"Nonadherence to national guidelines for antibiotic treatment of uncomplicated gonorrhea in China: results from a nationwide survey","volume":"45","author":"Han","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0041","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM197301252880404","article-title":"Clinical spectrum of pharyngeal gonococcal infection","volume":"288","author":"Wiesner","year":"1973","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.trsl.2020.02.002_bib0042","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0264-410X(91)90147-X","article-title":"Efficacy trial of a parenteral gonococcal pilus vaccine in men","volume":"9","author":"Boslego","year":"1991","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.trsl.2020.02.002_bib0043","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00325-18","article-title":"Aminomethyl spectinomycins as therapeutics for drug-resistant gonorrhea and chlamydia coinfections","volume":"62","author":"Butler","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0044","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bjm.2017.06.001","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: history, molecular mechanisms and epidemiological aspects of an emerging global threat","volume":"48","author":"Costa-Louren\u00e7o","year":"2017","journal-title":"Braz J Microbiol"},{"issue":"5","key":"10.1016\/j.trsl.2020.02.002_bib0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/sextrans-2015-052312","article-title":"An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England","volume":"92","author":"Chisholm","year":"2016","journal-title":"Sex Transm Infect"},{"issue":"5","key":"10.1016\/j.trsl.2020.02.002_bib0046","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3201\/eid2305.170088","article-title":"Azithromycin resistance and decreased ceftriaxone susceptibility in Neisseria gonorrhoeae, Hawaii, USA","volume":"23","author":"Papp","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0047","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/AAC.49.1.137-143.2005","article-title":"Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan","volume":"49","author":"Ito","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"27","key":"10.1016\/j.trsl.2020.02.002_bib0048","article-title":"Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018","volume":"23","author":"Eyre","year":"2018","journal-title":"Euro Surv"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0049","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3201\/eid2404.171873","article-title":"Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain","volume":"24","author":"Lahra","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0050","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3201\/eid2402.171756","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae, Canada, 2017","volume":"24","author":"Lefebvre","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002499","article-title":"Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: a retrospective study of national surveillance data from 2013 to 2016","volume":"15","author":"Yin","year":"2018","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.trsl.2020.02.002_bib0052","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance\u2014the need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.trsl.2020.02.002_bib0053","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1128\/AAC.00155-11","article-title":"Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009","volume":"55","author":"Mehta","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0054","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/OLQ.0000000000000961","article-title":"Resistance profile of Neisseria gonorrhoeae in KwaZulu-Natal, South Africa questioning the effect of the currently advocated dual therapy","volume":"46","author":"Rambaran","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.trsl.2020.02.002_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206419","article-title":"The first year of the global enhanced gonococcal antimicrobial surveillance programme (EGASP) in Bangkok, Thailand, 2015-2016","volume":"13","author":"Sirivongrangson","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.trsl.2020.02.002_bib0056","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1473-3099(18)30340-2","article-title":"Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin","volume":"18","author":"Whiley","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.trsl.2020.02.002_bib0057","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/cid\/ciu521","article-title":"The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea","volume":"59","author":"Kirkcaldy","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"10190","key":"10.1016\/j.trsl.2020.02.002_bib0058","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/S0140-6736(18)32817-4","article-title":"Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial","volume":"393","author":"Ross","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.trsl.2020.02.002_bib0059","article-title":"Gentamicin Alone inadequate to eradicate Neisseria gonorrhoeae from the pharynx","author":"Barbee","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trsl.2020.02.002_bib0060","series-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","article-title":"Aminoglycosides","author":"Leggett","year":"2020"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0061","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/OLQ.0000000000000693","article-title":"Susceptibility of Neisseria gonorrhoeae to gentamicin-gonococcal isolate surveillance project, 2015-2016","volume":"45","author":"Mann","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"14","key":"10.1016\/j.trsl.2020.02.002_bib0062","article-title":"Update on investigation of UK case of Neisseria gonorrhoeae with high-levelresistance to azithromycin and resistance to ceftriaxone acquired abroad","volume":"12","author":"England","year":"2018","journal-title":"Health Prot Rep"},{"key":"10.1016\/j.trsl.2020.02.002_bib0063","series-title":"Extensively drug-resistant (XDR)","year":"2018"},{"issue":"3","key":"10.1016\/j.trsl.2020.02.002_bib0064","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijantimicag.2015.05.007","article-title":"Neisseria gonorrhoeae and fosfomycin: Past, present and future","volume":"46","author":"Tesh","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cmi.2016.03.031","article-title":"Randomized controlled clinical trial on the efficacy of fosfomycin trometamol for uncomplicated gonococcal urethritis in men","volume":"22","author":"Yuan","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.trsl.2020.02.002_bib0066","series-title":"New AntiBiotic treatment options for uncomplicated anogenital GOnorrhoea (NABOGO), identifier: NCT03294395","year":"2017"},{"issue":"13","key":"10.1016\/j.trsl.2020.02.002_bib0067","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s40265-017-0790-5","article-title":"Delafloxacin: first global approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.trsl.2020.02.002_bib0068","doi-asserted-by":"crossref","DOI":"10.1097\/OLQ.0000000000000971","article-title":"Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, phase 3, multicenter, randomized study","author":"Hook","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0069","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/AAC.44.4.1102-1107.2000","article-title":"In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates","volume":"44","author":"Milatovic","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/mdr.2017.0054","article-title":"In vitro activity of sitafloxacin and additional newer generation fluoroquinolones against ciprofloxacin-resistant Neisseria gonorrhoeae isolates","volume":"24","author":"Hamasuna","year":"2018","journal-title":"Microb Drug Resist (Larchmont, NY)"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0071","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/apm.12777","article-title":"In vitro activity and time-kill curve analysis of sitafloxacin against a global panel of antimicrobial-resistant and multidrug-resistant Neisseria gonorrhoeae isolates","volume":"126","author":"Jonsson","year":"2018","journal-title":"APMIS"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0072","article-title":"Future prospects for Neisseria gonorrhoeae treatment","volume":"7","author":"Suay-Garc\u00eda","year":"2018","journal-title":"Antibiotics (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.trsl.2020.02.002_bib0073","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1071\/SH19034","article-title":"New treatment options for Neisseria gonorrhoeae in the era of emerging antimicrobial resistance","volume":"16","author":"Lewis","year":"2019","journal-title":"Sexual Health"},{"issue":"suppl_2","key":"10.1016\/j.trsl.2020.02.002_bib0074","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1093\/infdis\/jix132","article-title":"New horizons in Mycoplasma genitalium treatment","volume":"216","author":"Bradshaw","year":"2017","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0075","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1365-2133.2003.05582.x","article-title":"A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity","volume":"149","author":"Dawe","year":"2003","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.trsl.2020.02.002_bib0076","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1358\/dot.2008.44.7.1219561","article-title":"Sitafloxacin hydrate for bacterial infections","volume":"44","author":"Anderson","year":"2008","journal-title":"Drugs Today (Barc)"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0077","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jac\/dkn136","article-title":"Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae","volume":"62","author":"Okumura","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0078","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1128\/AAC.02316-12","article-title":"Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae","volume":"57","author":"Rodgers","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.trsl.2020.02.002_bib0079","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/cid\/civ478","article-title":"A phase 2 trial of oral solithromycin 1200 mg or 1000 mg as single-dose oral therapy for uncomplicated gonorrhea","volume":"61","author":"Hook","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.trsl.2020.02.002_bib0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1473-3099(19)30116-1","article-title":"Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial","volume":"19","author":"Chen","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.trsl.2020.02.002_bib0081","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/AAC.02820-15","article-title":"In vitro activity of gepotidacin, a novel triazaacenaphthylene bacterial topoisomerase inhibitor, against a broad spectrum of bacterial pathogens","volume":"60","author":"Biedenbach","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"7309","key":"10.1016\/j.trsl.2020.02.002_bib0082","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.trsl.2020.02.002_bib0083","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01221-18","article-title":"Microbiological analysis from a phase 2 randomized study in adults evaluating single oral doses of gepotidacin in the treatment of uncomplicated urogenital gonorrhea caused by Neisseria gonorrhoeae","volume":"62","author":"Scangarella-Oman","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0084","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/cid\/ciy145","article-title":"Gepotidacin for the treatment of uncomplicated urogenital gonorrhea: a phase 2, randomized, dose-ranging, single-oral dose evaluation","volume":"67","author":"Taylor","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trsl.2020.02.002_bib0085","series-title":"A study evaluating efficacy and safety of gepotidacin compared with ceftriaxone plus azithromycin in the treatment of uncomplicated urogenital gonorrhea, identifier: NCT04010539","year":"2019"},{"issue":"3","key":"10.1016\/j.trsl.2020.02.002_bib0086","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/AAC.04456-14","article-title":"Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae","volume":"59","author":"Alm","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0087","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/AAC.04124-14","article-title":"In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase\/topoisomerase inhibitor with potent activity against gram-positive, fastidious gram-negative, and atypical bacteria","volume":"59","author":"Huband","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.trsl.2020.02.002_bib0088","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1128\/AAC.03090-14","article-title":"High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea","volume":"58","author":"Jacobsson","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"19","key":"10.1016\/j.trsl.2020.02.002_bib0089","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","article-title":"Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea","volume":"379","author":"Taylor","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.02.002_bib0090","series-title":"Zoliflodacin in uncomplicated gonorrhoea","year":"2019"},{"key":"10.1016\/j.trsl.2020.02.002_bib0091","doi-asserted-by":"crossref","first-page":"39004","DOI":"10.1038\/srep39004","article-title":"A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanism","volume":"6","author":"Eyal","year":"2016","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.trsl.2020.02.002_bib0092","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/cid\/ciz090","article-title":"Efficacy and safety of intravenous-to-oral lefamulin, a pleuromutilin antibiotic, for the treatment of community-acquired bacterial pneumonia: the phase III lefamulin evaluation against pneumonia (LEAP 1) trial","volume":"69","author":"File","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.trsl.2020.02.002_bib0093","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.2019.15468","article-title":"Oral Lefamulin vs Moxifloxacin for early clinical response among adults with community-acquired bacterial pneumonia: the LEAP 2 randomized clinical trial","volume":"322","author":"Alexander","year":"2019","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.trsl.2020.02.002_bib0094","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.2019.16215","article-title":"Lefamulin\u2014a new antibiotic for community-acquired pneumonia","volume":"322","author":"Malani","year":"2019","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.trsl.2020.02.002_bib0095","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01497-17","article-title":"In vitro activity of the novel pleuromutilin lefamulin (BC-3781) and Effect of efflux pump inactivation on multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae","volume":"61","author":"Jacobsson","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.trsl.2020.02.002_bib0096","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02380-17","article-title":"In vitro activity of lefamulin against sexually transmitted bacterial pathogens","volume":"62","author":"Paukner","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.trsl.2020.02.002_bib0097","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1128\/AAC.43.11.2790","article-title":"In vitro susceptibilities of Neisseria gonorrhoeae to fatty acids and monoglycerides","volume":"43","author":"Bergsson","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0098","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00534-17","article-title":"Prevention of ophthalmia neonatorum caused by Neisseria gonorrhoeae using a fatty acid-based formulation","volume":"8","author":"Churchward","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.trsl.2020.02.002_bib0099","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","article-title":"Neisseria gonorrhoeae: drug resistance, mouse models, and vaccine development","volume":"71","author":"Rice","year":"2017","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.trsl.2020.02.002_bib0100","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.3389\/fmicb.2018.02688","article-title":"The MtrCDE efflux pump contributes to survival of Neisseria gonorrhoeae from human neutrophils and their antimicrobial components","volume":"9","author":"Handing","year":"2018","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0101","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01576-19","article-title":"Could dampening expression of the Neisseria gonorrhoeae mtrCDE-encoded efflux pump be a strategy to preserve currently or resurrect formerly used antibiotics to treat gonorrhea?","volume":"10","author":"Chen","year":"2019","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0102","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/AAC.00038-14","article-title":"Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae","volume":"58","author":"Golparian","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0103","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/sextrans-2016-052753","article-title":"Antiseptic mouthwash against pharyngeal Neisseria gonorrhoeae: a randomised controlled trial and an in vitro study","volume":"93","author":"Chow","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0104","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12879-017-2541-3","article-title":"A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol","volume":"17","author":"Chow","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"10","key":"10.1016\/j.trsl.2020.02.002_bib0105","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/OLQ.0000000000000661","article-title":"Neisseria gonorrhoeae transmission among men who have sex with men: an anatomical site-specific mathematical model evaluating the potential preventive impact of mouthwash","volume":"44","author":"Zhang","year":"2017","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.trsl.2020.02.002_bib0106","doi-asserted-by":"crossref","DOI":"10.1071\/SH18237","article-title":"Translating mouthwash use for gonorrhoea prevention into a public health campaign: identifying current knowledge and research gaps","author":"Chow","year":"2019","journal-title":"Sex Health"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0107","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3109\/1040841X.2015.1105782","article-title":"Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development","volume":"42","author":"Edwards","year":"2016","journal-title":"Crit Rev Microbiol"},{"issue":"4480","key":"10.1016\/j.trsl.2020.02.002_bib0108","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0140-6736(01)32510-2","article-title":"The treatment of gonococcus infections by vaccines","volume":"174","author":"Eyre","year":"1909","journal-title":"Lancet North Am Ed"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0109","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.trsl.2020.02.002_bib0110","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.138.12.4402","article-title":"An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues","volume":"138","author":"Finne","year":"1987","journal-title":"J Immunol"},{"issue":"751","key":"10.1016\/j.trsl.2020.02.002_bib0111","article-title":"The development of a vaccine against meningococcus B using reverse vaccinology","volume":"10","author":"Masignani","year":"2019","journal-title":"Front Immunol"},{"issue":"9869","key":"10.1016\/j.trsl.2020.02.002_bib0112","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(12)61961-8","article-title":"Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials","volume":"381","author":"Vesikari","year":"2013","journal-title":"Lancet North Am Ed"},{"issue":"10061","key":"10.1016\/j.trsl.2020.02.002_bib0113","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","author":"Parikh","year":"2016","journal-title":"Lancet North Am Ed"},{"issue":"9","key":"10.1016\/j.trsl.2020.02.002_bib0114","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/cid\/cix154","article-title":"Impact of an immunization campaign to control an increased incidence of serogroup B meningococcal disease in one region of Quebec, Canada","volume":"64","author":"De Wals","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.trsl.2020.02.002_bib0115","doi-asserted-by":"crossref","first-page":"520","DOI":"10.15585\/mmwr.mm6520a3","article-title":"notes from the field: outbreak of serogroup B meningococcal disease at a University - California, 2016","volume":"65","author":"Biswas","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5459","key":"10.1016\/j.trsl.2020.02.002_bib0116","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.trsl.2020.02.002_bib0117","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1600-0463.2012.02903.x","article-title":"Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae","volume":"120","author":"Hadad","year":"2012","journal-title":"APMIS"},{"issue":"10102","key":"10.1016\/j.trsl.2020.02.002_bib0118","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet North Am Ed"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0119","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7010005","article-title":"Effectiveness of a Group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: a retrospective cohort study","volume":"7","author":"Paynter","year":"2019","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0120","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/mi.2017.11","article-title":"Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model","volume":"10","author":"Liu","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0121","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/infdis\/174.6.1238","article-title":"Experimental immunization with a monoclonal anti-idiotope antibody that mimics the Neisseria gonorrhoeae lipooligosaccharide epitope 2C7","volume":"174","author":"Gulati","year":"1996","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.trsl.2020.02.002_bib0122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003559","article-title":"Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection","volume":"9","author":"Gulati","year":"2013","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0123","doi-asserted-by":"crossref","first-page":"e02552","DOI":"10.1128\/mBio.02552-19","article-title":"Preclinical efficacy of a lipooligosaccharide peptide mimic candidate gonococcal vaccine","volume":"10","author":"Gulati","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.trsl.2020.02.002_bib0124","doi-asserted-by":"crossref","DOI":"10.1071\/SH19060","article-title":"Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap","author":"Gottlieb","year":"2019","journal-title":"Sex Health"},{"issue":"11","key":"10.1016\/j.trsl.2020.02.002_bib0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrurol.2017.139","article-title":"Infection: proof of principle for effectiveness of a gonorrhoea vaccine","volume":"14","author":"Unemo","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.trsl.2020.02.002_bib0126","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fimmu.2019.00683","article-title":"Exploitation of Neisseria meningitidis Group B OMV vaccines against N. gonorrhoeae to Inform the development and deployment of effective gonorrhea vaccines","volume":"10","author":"Petousis-Harris","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0127","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1155\/2005\/323082","article-title":"The laboratory diagnosis of Neisseria gonorrhoeae","volume":"16","author":"Ng","year":"2005","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0732-8893(93)90017-2","article-title":"Use of molecular diagnostics in sexually transmitted diseases critical assessment","volume":"16","author":"Chapin-Robertson","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/OLQ.0000000000000553","article-title":"Increased detection of pharyngeal and rectal gonorrhea in men who have sex with men after transition from culture to nucleic acid amplification testing","volume":"44","author":"Cornelisse","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001598","article-title":"Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea","volume":"11","author":"Low","year":"2014","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2353\/jmoldx.2006.050045","article-title":"Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge","volume":"8","author":"Whiley","year":"2006","journal-title":"J Mol Diagn"},{"issue":"5","key":"10.1016\/j.trsl.2020.02.002_bib0132","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/JCM.02398-09","article-title":"Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis","volume":"48","author":"Bachmann","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0133","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1128\/JCM.01581-08","article-title":"Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections","volume":"47","author":"Bachmann","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"S4","key":"10.1016\/j.trsl.2020.02.002_bib0134","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1136\/sextrans-2016-053072","article-title":"Rapid accurate point-of-care tests combining diagnostics and antimicrobial resistance prediction for Neisseria gonorrhoeae and Mycoplasma genitalium","volume":"93","author":"Sadiq","year":"2017","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.trsl.2020.02.002_bib0135","article-title":"Raises $15 million from U.S. investment partnership [Internet]","year":"2019","journal-title":"Bloomberg.com,"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0136","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/JCM.03461-12","article-title":"Performance of the cepheid CT\/NG Xpert Rapid PCR test for detection of chlamydia trachomatis and Neisseria gonorrhoeae","volume":"51","author":"Gaydos","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.trsl.2020.02.002_bib0137","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1128\/JCM.01930-12","article-title":"Performance of the GeneXpert CT\/NG assay compared to that of the Aptima AC2 assay for detection of rectal Chlamydia trachomatis and Neisseria gonorrhoeae by use of residual Aptima Samples","volume":"50","author":"Goldenberg","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0138","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1128\/JCM.00806-13","article-title":"Analytical evaluation of GeneXpert CT\/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis","volume":"51","author":"Tabrizi","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0139","doi-asserted-by":"crossref","first-page":"e00537","DOI":"10.1128\/JCM.00537-19","article-title":"GeneXpert MTB\/RIF is superior to BBD Max MDR-TB for diagnosis of tuberculosis (TB) in a country with low incidence of multidrug-resistant TB (MDR-TB)","volume":"57","author":"Mokaddas","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.trsl.2020.02.002_bib0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1109\/TBME.2010.2095851","article-title":"Evaluation of a novel electrochemical detection method for Chlamydia trachomatis: application for point-of-care diagnostics","volume":"58","author":"Pearce","year":"2011","journal-title":"IEEE Trans Biomed Eng"},{"key":"10.1016\/j.trsl.2020.02.002_bib0141","series-title":"The point-of-care diagnostic landscape for sexually transmitted infections (STIs)","author":"Murtagh","year":"2018"},{"issue":"3","key":"10.1016\/j.trsl.2020.02.002_bib0142","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrurol.2016.268","article-title":"Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium","volume":"14","author":"Unemo","year":"2017","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0143","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/s41467-018-06634-y","article-title":"Machine learning and structural analysis of Mycobacterium tuberculosis pan-genome identifies genetic signatures of antibiotic resistance","volume":"9","author":"Kavvas","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0144","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s12864-019-5820-0","article-title":"Identifying genetic determinants of complex phenotypes from whole genome sequence data","volume":"20","author":"Long","year":"2019","journal-title":"BMC Genom"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0145","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01260-18","article-title":"Using machine learning to predict antimicrobial MICs and associated genomic features for nontyphoidal Salmonella","volume":"57","author":"Nguyen","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0146","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00123-17","article-title":"Machine learning leveraging genomes from metagenomes identifies influential antibiotic resistance genes in the infant gut microbiome","volume":"3","author":"Rahman","year":"2018","journal-title":"mSystems"},{"issue":"9","key":"10.1016\/j.trsl.2020.02.002_bib0147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007349","article-title":"Evaluation of parameters affecting performance and reliability of machine learning-based antibiotic susceptibility testing from whole genome sequencing data","volume":"15","author":"Hicks","year":"2019","journal-title":"PLoS Comput Biol"},{"issue":"8","key":"10.1016\/j.trsl.2020.02.002_bib0148","doi-asserted-by":"crossref","first-page":"e00549","DOI":"10.1128\/AAC.00549-19","article-title":"Impact of species diversity on the design of RNA-based diagnostics for antibiotic resistance in Neisseria gonorrhoeae","volume":"63","author":"Wadsworth","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0149","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1038\/s41598-018-29707-w","article-title":"RNA markers enable phenotypic test of antibiotic susceptibility in Neisseria gonorrhoeae after 10\u2009minutes of ciprofloxacin exposure","volume":"8","author":"Khazaei","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.trsl.2020.02.002_bib0150","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41591-019-0650-9","article-title":"Simultaneous detection of genotype and phenotype enables rapid and accurate antibiotic susceptibility determination","volume":"25","author":"Bhattacharyya","year":"2019","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0151","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/infdis\/jiv517","article-title":"Improving control of antibiotic-resistant gonorrhea by integrating research agendas across disciplines: key questions arising from mathematical modeling","volume":"213","author":"Grad","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0152","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12916-017-0881-x","article-title":"Detection of antibiotic resistance is essential for gonorrhoea point-of-care testing: a mathematical modelling study","volume":"15","author":"Fingerhuth","year":"2017","journal-title":"BMC medicine"},{"issue":"6","key":"10.1016\/j.trsl.2020.02.002_bib0153","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015447","article-title":"Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Neisseria gonorrhoeae a modelling study","volume":"7","author":"Turner","year":"2017","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.trsl.2020.02.002_bib0154","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/infdis\/jix450","article-title":"Impact of rapid susceptibility testing and antibiotic selection strategy on the emergence and spread of antibiotic resistance in gonorrhea","volume":"216","author":"Tuite","year":"2017","journal-title":"J Infect Dis"},{"issue":"36","key":"10.1016\/j.trsl.2020.02.002_bib0155","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.vaccine.2015.07.015","article-title":"The potential impact of vaccination on the prevalence of gonorrhea","volume":"33","author":"Craig","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.trsl.2020.02.002_bib0156","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1128\/CVI.00230-16","article-title":"Summary and recommendations from the national institute of allergy and infectious diseases (NIAID) workshop \u201cgonorrhea vaccines: the way forward\u201d","volume":"23","author":"Wetzler","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.trsl.2020.02.002_bib0157","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1475-9276-10-27","article-title":"Global challenges of implementing human papillomavirus vaccines","volume":"10","author":"Graham","year":"2011","journal-title":"Int J Equity Health"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0158","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12913-016-1824-5","article-title":"Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014","volume":"16","author":"Ladner","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.trsl.2020.02.002_bib0159","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1200\/EDBK_249695","article-title":"HPV vaccination in Latin America: global challenges and feasible solutions","volume":"39","author":"Nogueira-Rodrigues","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"2-3","key":"10.1016\/j.trsl.2020.02.002_bib0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.14745\/ccdr.v45i23a02","article-title":"Addressing the rising rates of gonorrhea and drug-resistant gonorrhea: There is no time like the present","volume":"45","author":"Bodie","year":"2019","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.trsl.2020.02.002_bib0161","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz153","article-title":"Population-level antimicrobial consumption is associated with decreased antimicrobial susceptibility in Neisseria gonorrhoeae in 24 European countries: an ecological analysis","author":"Kenyon","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trsl.2020.02.002_bib0162","article-title":"Deciphering the impact of bystander selection for antibiotic resistance in Neisseria gonorrhoeae","author":"Olesen","year":"2019","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.trsl.2020.02.002_bib0163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000547","article-title":"Surveillance to maintain the sensitivity of genotype-based antibiotic resistance diagnostics","volume":"17","author":"Hicks","year":"2019","journal-title":"PLoS Biol"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0164","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/nyas.13871","article-title":"Applications of genomics to slow the spread of multidrug-resistant Neisseria gonorrhoeae","volume":"1435","author":"Mortimer","year":"2019","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.trsl.2020.02.002_bib0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013045","article-title":"Safetxt: a pilot randomised controlled trial of an intervention delivered by mobile phone to increase safer sex behaviours in young people","volume":"6","author":"McCarthy","year":"2016","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.trsl.2020.02.002_bib0166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23120","article-title":"Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility study","volume":"23","author":"King","year":"2019","journal-title":"Health Technol Assess"},{"issue":"7","key":"10.1016\/j.trsl.2020.02.002_bib0167","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.olq.0000135301.97350.84","article-title":"Prevention of gonorrhea and Chlamydia through behavioral intervention: results of a two-year controlled randomized trial in minority women","volume":"31","author":"Shain","year":"2004","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.trsl.2020.02.002_bib0168","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.trsl.2020.02.002_bib0169","series-title":"Gonococcal antimicrobial susceptibility surveillance in Europe - results summary 2017. ECDC surveillance report","year":"2019"},{"key":"10.1016\/j.trsl.2020.02.002_bib0170","article-title":"Australian gonococcal surveillance programme annual report, 2017","volume":"43","author":"Lahra","year":"2019","journal-title":"Commun Dis Intell (2018)"},{"issue":"2","key":"10.1016\/j.trsl.2020.02.002_bib0171","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1074\/jbc.M805761200","article-title":"Crystal structures of penicillin-binding protein 2 from penicillin-susceptible and -resistant strains of Neisseria gonorrhoeae reveal an unexpectedly subtle mechanism for antibiotic resistance","volume":"284","author":"Powell","year":"2009","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.trsl.2020.02.002_bib0172","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1128\/AAC.49.10.4327-4334.2005","article-title":"High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants","volume":"49","author":"Hu","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.trsl.2020.02.002_bib0173","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1086\/386312","article-title":"Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies","volume":"189","author":"Giles","year":"2004","journal-title":"J Infect Dis"},{"issue":"6802","key":"10.1016\/j.trsl.2020.02.002_bib0174","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/35030019","article-title":"Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics","volume":"407","author":"Carter","year":"2000","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.trsl.2020.02.002_bib0175","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nrmicro1265","article-title":"The bacterial ribosome as a target for antibiotics","volume":"3","author":"Poehlsgaard","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.trsl.2020.02.002_bib0176","series-title":"Gonococcal antimicrobial susceptibility surveillance in Europe - 2016. ECDC surveillance report","year":"2018"},{"issue":"10","key":"10.1016\/j.trsl.2020.02.002_bib0177","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01221-19","article-title":"Trends and risk factors for antimicrobial-resistant Neisseria gonorrhoeae, Melbourne, Australia, 2007 to 2018","volume":"63","author":"Williamson","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl T1","key":"10.1016\/j.trsl.2020.02.002_bib0178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/48.suppl_2.1","article-title":"Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site","volume":"48","author":"Douthwaite","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.trsl.2020.02.002_bib0179","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3201\/eid0301.970104","article-title":"Fluoroquinolone resistance in Neisseria gonorrhoeae","volume":"3","author":"Knapp","year":"1997","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.trsl.2020.02.002_bib0180","article-title":"Fosfomycin: pharmacological, clinical and future perspectives","volume":"6","author":"Dijkmans","year":"2017","journal-title":"Antibiotics (Basel, Switzerland)"},{"issue":"suppl 1","key":"10.1016\/j.trsl.2020.02.002_bib0181","first-page":"117","article-title":"Safety and efficacy of antimicrobial mouthrinses in clinical practice","volume":"81","author":"DePaola","year":"2007","journal-title":"Am Dent Hyg Assoc"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420300311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420300311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:42:50Z","timestamp":1761828170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524420300311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":181,"alternative-id":["S1931524420300311"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2020.02.002","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2020.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}